Joseph V. Bonventre

Joseph V. Bonventre is a distinguished professor at Harvard University, where he holds a senior faculty position and leads a major research program in nephrology. He earned his medical degree from Harvard Medical School and completed his clinical training in internal medicine and nephrology at Brigham and Women's Hospital. Dr. Bonventre's research program centers on understanding the molecular mechanisms underlying acute kidney injury (AKI) and its progression to chronic kidney disease (CKD), with particular emphasis on diabetic nephropathy and renal malignancies. His laboratory employs multidisciplinary approaches ranging from molecular biology and physiology to advanced imaging techniques and clinical epidemiology. A major focus of his work involves identifying novel biomarkers for early detection and prognosis of kidney diseases, as evidenced by his development of the Joslin Kidney Panel of circulating proteins. His recent clinical trial work investigates interventions like nitric oxide administration to prevent AKI in high-risk surgical patients. Dr. Bonventre has made seminal contributions to understanding renal cell responses to injury and regeneration, with his research consistently published in top-tier journals including the Journal of the American Society of Nephrology and Clinical Journal of the American Society of Nephrology. Bonventre has established a strong presence in the field. Their research directions are illustrated by key works including "Urine Biomarkers of Kidney Tubule Health and Risk of Incident CKD in Persons Without Diabetes: The ARIC, MESA, and REGARDS Studies", and "Cytosolic phospholipase A2 regulates Golgi structure and modulates intracellular trafficking of membrane proteins".